Have you or has your son been harmed by Risperdal?
If you or a loved one have taken Risperdal and as a result, suffered gynecomastia, you may be able to hold the Johnson & Johnson’s Janssen Pharmaceuticals responsible. The drug Risperdal (risperidone) is an antipsychotic that the U.S. Food and Drug Administration approved for the treatment of schizophrenia, acute manic or mixed episodes associated with Bipolar I, and irritability associated with autistic disorder. The FDA originally approved Risperdal in 1993. At the time, the drug was not approved for use by youth.
Gynecomastia is the swelling of breast tissue in males with or without lactation.
The criteria for an eligible Risperdal claim includes:
Under 30 or 60-66 at time of Risperdal or Risperidone use
At least one month prescription of a J&J Risperidone, Invega or Risperdal product
Noticeable breast growth, lactation and/or diagnosis of Gynecomastianking and finance tax